Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akito Hata

Showing results (11-20 of 146) with videos related to

Pageof 15
Sort By:
Thoracic Cancer|July 6, 2022
Heterogeneity or transformation? A whack-a-mole case of EGFR-mutant lung adenocarcinoma and small cell carcinoma: A case reportTaira Ninomaru, Akito Hata, Shigeo Hara, et al.
JTO Clinical and Research Reports|August 18, 2025
Tocilizumab for Steroid Pulse-Refractory Cytokine Release Syndrome in Chemotherapy With Durvalumab Plus Tremelimumab for NSCLC: A Case ReportKen Yamamoto, Katsuya Hirano, Temiko Shimada, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 20, 2012
Erlotinib for whole-brain-radiotherapy-refractory leptomeningeal metastases after gefitinib failure in a lung adenocarcinoma patientAkito Hata, Nobuyuki Katakami, Reiko Kaji, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 24, 2010
Bilateral subdural hematoma associated with central nervous system metastases from lung cancerAkito Hata, Shiro Fujita, Nobuyuki Katakami, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 27, 2014
Spatiotemporal T790M heterogeneity in a patient with EGFR-mutant non-small-cell lung cancerAkito Hata, Katsuhiro Masago, Nobuyuki Katakami, et al.
Frontiers in Immunology|May 27, 2024
Case report: Inflammatory sternoclavicular joint arthritis induced by an immune checkpoint inhibitor with remarkable responsiveness to infliximabShion Kachi, Shuji Sumitomo, Hideki Oka, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 31, 2011
Angiosarcoma arising from right atrium: remarkable response to concurrent chemoradiotherapy with carboplatin and paclitaxelAkito Hata, Nobuyuki Katakami, Shiro Fujita, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 15, 2013
Does T790M disappear? Successful gefitinib rechallenge after T790M disappearance in a patient with EGFR-mutant non-small-cell lung cancerAkito Hata, Nobuyuki Katakami, Reiko Kaji, et al.
Internal Medicine (Tokyo, Japan)|March 2, 2013
Dose reduction or intermittent administration of erlotinib: which is better for patients suffering from intolerable toxicities?Akito Hata, Shiro Fujita, Reiko Kaji, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 31, 2011
Do complex mutations of the epidermal growth factor receptor gene reflect intratumoral heterogeneity?Akito Hata, Shiro Fujita, Reiko Kaji, et al.
Pageof 15

Showing results (11-20 of 146) with videos related to

Sort By:
Pageof 15
Thoracic Cancer|July 6, 2022
Heterogeneity or transformation? A whack-a-mole case of EGFR-mutant lung adenocarcinoma and small cell carcinoma: A case reportTaira Ninomaru, Akito Hata, Shigeo Hara, et al.
JTO Clinical and Research Reports|August 18, 2025
Tocilizumab for Steroid Pulse-Refractory Cytokine Release Syndrome in Chemotherapy With Durvalumab Plus Tremelimumab for NSCLC: A Case ReportKen Yamamoto, Katsuya Hirano, Temiko Shimada, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 20, 2012
Erlotinib for whole-brain-radiotherapy-refractory leptomeningeal metastases after gefitinib failure in a lung adenocarcinoma patientAkito Hata, Nobuyuki Katakami, Reiko Kaji, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 24, 2010
Bilateral subdural hematoma associated with central nervous system metastases from lung cancerAkito Hata, Shiro Fujita, Nobuyuki Katakami, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 27, 2014
Spatiotemporal T790M heterogeneity in a patient with EGFR-mutant non-small-cell lung cancerAkito Hata, Katsuhiro Masago, Nobuyuki Katakami, et al.
Frontiers in Immunology|May 27, 2024
Case report: Inflammatory sternoclavicular joint arthritis induced by an immune checkpoint inhibitor with remarkable responsiveness to infliximabShion Kachi, Shuji Sumitomo, Hideki Oka, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 31, 2011
Angiosarcoma arising from right atrium: remarkable response to concurrent chemoradiotherapy with carboplatin and paclitaxelAkito Hata, Nobuyuki Katakami, Shiro Fujita, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 15, 2013
Does T790M disappear? Successful gefitinib rechallenge after T790M disappearance in a patient with EGFR-mutant non-small-cell lung cancerAkito Hata, Nobuyuki Katakami, Reiko Kaji, et al.
Internal Medicine (Tokyo, Japan)|March 2, 2013
Dose reduction or intermittent administration of erlotinib: which is better for patients suffering from intolerable toxicities?Akito Hata, Shiro Fujita, Reiko Kaji, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 31, 2011
Do complex mutations of the epidermal growth factor receptor gene reflect intratumoral heterogeneity?Akito Hata, Shiro Fujita, Reiko Kaji, et al.
Pageof 15